Original ContributionImplementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement☆
Section snippets
Background
Bipolar disorder is a chronic illness affecting up to 5.5% of the population [1] and is associated with substantial functional limitations [2], [3] and health care costs [4], [5]. Persons with bipolar disorder often require intensive pharmacologic and psychosocial treatment [2], because the illness is uniquely characterized by alternating periods of mania and depression, which can lead to treatment interruptions and self-medication with substance abuse that impede overall treatment adherence [6]
Study population and sample
We analyzed data from a longitudinal, naturalistic, population-based study of 435 veterans with mood disorders [19]. The target population was patients being treated for bipolar disorder presenting for inpatient or outpatient care during a 2-year period (July 2004–July 2006) at a large VA mental health facility. Patients who were clinically diagnosed with bipolar disorder (including bipolar I disorder as well as the spectrum disorders including bipolar II or schizoaffective disorder–bipolar
Results
The sample (N=433) was 86% male, 77% white and had a mean age of 49 years (range 21–78). Overall, 74% of the sample was diagnosed with bipolar I, 9% diagnosed with bipolar II and 17% diagnosed with schizoaffective disorder-bipolar subtype. Half (54%) reported a history of homelessness and 28% reported a history of illicit drug use (Table 2).
The denominator was the same for each indicator (N=433). Overall, 17% had documented assessment of all symptoms (delusional, psychotic, hallucinatory), 56%
Discussion
To our knowledge, this is one of the few studies to apply operationalized processes of care that represent a wider range of services beyond medication use for patients with bipolar disorder and determine the patient factors associated with receipt of adequate processes of care in this group. This is also one of the first studies to propose patient-centered composite measures for assessing quality of care for bipolar disorder. We found that, although certain aspects of bipolar care were
References (37)
- et al.
The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases
J Affect Disord
(2003) - et al.
Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study
J Affect Disord
(2001) - et al.
The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO
Gen Hosp Psychiatry
(2000) - et al.
Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder
J Affect Disord
(2005) - et al.
Bipolar disorder
Ment Health Serv Res
(2002) - et al.
Health care utilization and costs among patients treated for bipolar disorder in an insured population
Psychiat Serv
(1999) - et al.
Insurance expenditures on bipolar disorder: clinical and parity implications
Am J Psychiatry
(2003) - et al.
12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode
Am J Psychiatry
(1998) - et al.
The global burden of disease, 1990–2020
Nat Med
(1998) Practice guideline for the treatment of patients with bipolar disorder (revision)
Am J Psychiatry
(2002)
Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder
Psychopharmacol Bull
Report of the texas consensus conference panel on medication treatment of bipolar disorder 2000
J Clin Psychiatry
Trends in the treatment of bipolar disorder by outpatient psychiatrists
Am J Psychiatry
Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder
Am J Psychiatry
Quality of care in a Medicaid population with bipolar I disorder
Psychiatr Serv
The Definition of Quality and Approaches to Its Assessment. Explorations in Quality Assessment and Monitoring
Quality of care measures for the treatment of bipolar disorder
Psychiatr Q
Bipolar-I depression outpatient treatment quality and costs in usual care practice
Psychopharmacol Bull
Cited by (13)
Basic quality indicators for clinical care of patients with major depression, schizophrenia, and bipolar disorder
2023, Revista de Psiquiatria y Salud MentalDoes guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?
2021, Journal of Affective DisordersCitation Excerpt :However, concordance rates cannot be easily compared due to the differences in study designs, guidelines assessed, illness stage, bipolar disorder presentations and treatment settings. Most studies solely examined the use of pharmacotherapy although some had evaluated the use of non-pharmacological treatment options including psychoeducation (Renes et al., 2018), psychotherapy (Renes et al., 2018) or clinician assessments (Kilbourne et al., 2010). In contrast, we utilized recommendations that incorporated multimodal treatment strategies such as family psychoeducation, CBT-informed care and maintenance pharmacotherapy using prospective clinical data.
Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders
2016, Journal of Substance Abuse TreatmentCitation Excerpt :There are no reliable and valid process-based, quality measures that have been developed and tested for individuals with co-occurring disorders (Dausey, Pincus, & Herrell, 2009). Thus, although care for individuals with mental and/or substance use disorders varies across treatment systems (Watkins, Pincus, et al., 2011; Watkins et al., 2015), and settings (Charbonneau et al., 2003; Harris et al., 2009; Kilbourne et al., 2010; Lee et al., 2014), differences in the process of care have not been linked to differences in patient outcomes, and there are no process-based quality measures that predict improved outcomes. Thus it is unknown whether improvements in treatment process would lead to improvements in patient outcomes.
The impact of mood symptomatology on pattern of substance use among homeless
2015, Journal of Affective DisordersCitation Excerpt :Bipolar depression is of particular interest in homeless populations because individuals with bipolar disorder have higher rates of homelessness, compared to those with unipolar depression (Folsom et al., 2005). Similarly, patients who had a history of homelessness have increased odds of being assessed for bipolar symptoms (Kilbourne et al., 2010). In recent studies, bipolar disorder, particularly lifetime hypomanic symptoms were found to be present in 40–44% of a Canadian homeless population (Krausz et al., 2013; Schutz et al., 2013).
Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder
2012, Contemporary Clinical TrialsCitation Excerpt :Global functioning was measured using the 12-item World Health Organization Disability Assessment Scale (WHO-DAS) that assesses the degree of functional impairment experienced over the past month regarding self-care, mobility, cognition, social functioning, and role functioning. Primary utilization measures of interest included outpatient primary care services, inpatient and ER use, and health care costs based on chart reviews using a standard assessment tool [69]. Patient surveys also provided information on demographic and health variables that might moderate LGCC effectiveness.
Quality indicators in the treatment of patients with depression, bipolar disorder or schizophrenia. Consensus study
2018, Revista de Psiquiatria y Salud Mental
- ☆
This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (IIR 02-283) and by the National Institute of Mental Health (MH 74509; MH 79994, T32 MH19986). The funding source had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. All authors warrant having no actual or perceived conflicts of interest — financial or nonfinancial — in the procedures described in this manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.